Glusita Plus
Active ingredient not listed in the SAHPRA register
Sandoz South Africa (Pty) Ltd
Registration
- Applicant
- Sandoz South Africa (Pty) Ltd
- Registrations
- 3
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Glusita plus 50/500 MG SITAGLIPTIN; METFORMIN HYDROCHLORIDE | 50/500 mg | 55067655/21.2/0676 | Registered | Not determined | None |
| Glusita plus 50/850 MG SITAGLIPTIN; METFORMIN HYDROCHLORIDE | 50/850 mg | 55067755/21.2/0677 | Registered | Not determined | None |
| Glusita plus 50/1 000 MG SITAGLIPTIN; METFORMIN HYDROCHLORIDE | 000 mg 50/1 | 55067855/21.2/0678 | Registered | Not determined | None |
Regulatory status
This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
No structure available
The SAHPRA register lists no active ingredient for this product, so there is no compound to show.
SAHPRA documents
SAHPRA has not published a professional information or patient information leaflet for this product.